Voyager Labs Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Voyager Labs's estimated annual revenue is currently $13.3M per year.(i)
  • Voyager Labs's estimated revenue per employee is $145,000

Employee Data

  • Voyager Labs has 92 Employees.(i)
  • Voyager Labs grew their employee count by -7% last year.

Voyager Labs's People

NameTitleEmail/Phone
1
EVP & General Manager LATAMReveal Email/Phone
2
Regional Technical Account Manager EMEAReveal Email/Phone
3
Technical WriterReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.6M142-18%N/AN/A
#2
$41.3M25944%N/AN/A
#3
$808.8M39849%N/AN/A
#4
$1320M19018%$445MN/A
#5
$513.8M247811%$215MN/A
#6
$16.7M1154%N/AN/A
#7
$469.4M22648%$298.8MN/A
#8
$84.3M46533%N/AN/A
#9
$19.4M127-2%$46.6MN/A
#10
$81.2M44825%N/AN/A
Add Company

What Is Voyager Labs?

Voyager Labs, a world leader in the AI space, enables investigators and analysts to acquire actionable, previously unattainable insights by analyzing and understanding massive amounts of open, deep, and dark web data. Leading government, law enforcement agencies and corporations around the world use our award-winning, cutting-edge technology, coupled with superior domain expertise, to exponentially increase productivity of their investigative teams, elevate their quality of investigation and ultimately mitigate and prevent risks to make a safer world. To learn more, visit www.voyagerlabs.co or email us at team@voyagerlabs.co

keywords:N/A

N/A

Total Funding

92

Number of Employees

$13.3M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Voyager Labs News

2022-03-22 - Roger Perlmutter lures Roy Baynes away from Merck; Now ...

Another big name at the pharma giant, Merck Research Laboratories CMO Roy ... has ascended to CEO at Voyager, the gene therapy biotech that...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23M926%N/A
#2
$29.9M922%N/A
#3
$24.8M9211%$28.8M
#4
$23M9210%N/A
#5
$12M92-11%$64M